Bacteria News and Research

RSS

Staph-killing compound may be effective against osteomyelitis

Osteomyelitis - a debilitating bone infection most frequently caused by Staphylococcus aureus ("staph") bacteria - is particularly challenging to treat.

20 Jun 2013

Spodak Dental Group offers tips to keep your mouth healthy

You know the importance of brushing two or three times a day, and flossing at least once a day, in maintaining good oral health. But did you know there are other measures you should also take if you want to keep your teeth for a lifetime? Keep your mouth healthy by following these simple tips provided by Spodak Dental Group:

19 Jun 2013

Scientists discover new drug that cripples TB bug by dissolving its protective fatty coating

Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.

19 Jun 2013

Scientists discover new mechanism to protect body from harmful bacteria

Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.

19 Jun 2013

Doctoral research shows role of immune system in development of resistance to antibiotics

Leon Cantas' doctoral research shows that the immune response of the host to a bacterial infection may have a significant effect on the development of bacteria's resistance to antibiotics.

19 Jun 2013

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

18 Jun 2013

Antibiotic with clinical potential can stimulate own production, say scientists

An antibiotic has been found to stimulate its own production. The findings, to be published in PNAS, could make it easier to scale up antibiotic production for commercialisation.

18 Jun 2013

Multidisciplinary health care approach can cut the rate of common airway infection among children

An initiative that combines a multidisciplinary health care approach with a range of preventive measures could cut the rate of a common airway infection among children in intensive care by more than half, a new study suggests.

18 Jun 2013

New technique offers potential to screen patients for viruses

In research published in Biochemical and Biophysical Research Communications, Saint Louis University researchers describe a technology that can detect new, previously unknown viruses. The technique offers the potential to screen patients for viruses even when doctors have not identified a particular virus as the likely source of an infection.

18 Jun 2013

Mannitol could prevent aggregation of toxic proteins in the brain, says Tel Aviv University researcher

Mannitol, a sugar alcohol produced by fungi, bacteria, and algae, is a common component of sugar-free gum and candy. The sweetener is also used in the medical field - it's approved by the FDA as a diuretic to flush out excess fluids and used during surgery as a substance that opens the blood/brain barrier to ease the passage of other drugs.

18 Jun 2013

TSRI scientists identify highly promising new anti-tuberculosis compound

An international team led by scientists at The Scripps Research Institute, the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis bacterium in two different ways.

18 Jun 2013

Academies recommend ways to prevent antibiotic resistance, to develop antibiotics more quickly

Joint press release by the Academy of Sciences and Humanities in Hamburg and the German National Academy of Sciences Leopoldina

17 Jun 2013

Comparison of 1,000-year-old and modern bacterial genomes provides insights into history of leprosy pathogen

From skeletons and biopsies, an international team of scientists was successful in reconstructing a dozen medieval and modern genomes of the leprosy-causing bacteria Mycobacterium leprae.

15 Jun 2013

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Opioids, such as morphine, are still the most effective class of painkillers, but they come with unwanted side effects and can also be addictive and deadly at high doses. Designing new pain-killing drugs of this type involves testing them on their corresponding receptors, but access to meaningful quantities of these receptors that can work in experimental conditions has always been a limiting factor.

15 Jun 2013

Vestergaard Frandsen, PackH2O honored for developing products to help address global water crisis

The Children's Environmental Literacy Foundation Wednesday honored two organizations who have developed ground-breaking products to help address the global water crisis at its 10th anniversary gala held at the Tribeca Rooftop.

15 Jun 2013

Study: Shiga toxin-producing E. coli survive longer in recreational water, can prove dangerous to humans

A toxin dangerous to humans may help E. coli fend off aquatic predators, enabling strains of E. coli that produce the toxin to survive longer in lake water than benign counterparts, a new study finds.

14 Jun 2013

Scientists genetically engineer E. coli bacteria addicted to caffeine

The latest episode in the American Chemical Society's award-winning Global Challenges/Chemistry Solutions podcast series describes bacteria that are "addicted" to caffeine in a way that promises practical uses ranging from decontamination of wastewater to bioproduction of medications for asthma.

14 Jun 2013

Study provides new insight into how pyrazinamide works

Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.

14 Jun 2013

Researchers create guidelines to reduce staph infections after surgery

Staph infections in hospitals are a serious concern, so much so that the term Methicillin-resistant Staphylococcus aureus is as commonly known as MRI. Far less known is that in many of these cases, patients are infecting themselves.

13 Jun 2013

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route.

13 Jun 2013

Bacteria News and Research

Staph-killing compound may be effective against osteomyelitis

Spodak Dental Group offers tips to keep your mouth healthy

Scientists discover new drug that cripples TB bug by dissolving its protective fatty coating

Scientists discover new mechanism to protect body from harmful bacteria

Doctoral research shows role of immune system in development of resistance to antibiotics

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

Antibiotic with clinical potential can stimulate own production, say scientists

Multidisciplinary health care approach can cut the rate of common airway infection among children

New technique offers potential to screen patients for viruses

Mannitol could prevent aggregation of toxic proteins in the brain, says Tel Aviv University researcher

TSRI scientists identify highly promising new anti-tuberculosis compound

Academies recommend ways to prevent antibiotic resistance, to develop antibiotics more quickly

Comparison of 1,000-year-old and modern bacterial genomes provides insights into history of leprosy pathogen

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Vestergaard Frandsen, PackH2O honored for developing products to help address global water crisis

Study: Shiga toxin-producing E. coli survive longer in recreational water, can prove dangerous to humans

Scientists genetically engineer E. coli bacteria addicted to caffeine

Study provides new insight into how pyrazinamide works

Researchers create guidelines to reduce staph infections after surgery

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo